Literature DB >> 34476197

Intrapatient repeatability of background 18F-FDG uptake on PET/CT.

Rang Wang1, Qiuping Fan1, Rong Tian1, Minggang Su1.   

Abstract

BACKGROUND: Background activity is often used as a reference to assess tumor treatment response on positron emission tomography with 2-deoxy-2-[fluorine-18] fluoro-D-glucose integrated with computed tomography (18F-FDG PET/CT). Our objective was to find the preferred background by assessing the repeatability of its activity. The activity was expressed by a standardized uptake value normalized to lean body mass (SUL).
METHODS: Patients who received repeat 18F-FDG PET/CT scans within 1 to 4 days were selected. The indications included cancer screening, tumor staging, or treatment response evaluation. Background SULs from the aortic blood pool (ABP), liver, and muscle were recorded. Intraclass correlation coefficients (ICCs), the coefficient of variation (CV), and Bland-Altman plots for repeated measures were used to evaluate the degree of repeatability between the two scans. Intrapatient variation in SULs and factors, including the blood glucose level (BGL), tracer uptake period, and dose, were calculated as relative changes between the two scans. A linear regression model was used to analyze all relative changes to identify the correlation between factors and SULs.
RESULTS: Thirty patients were included. The SUL ICCs for the ABP, liver, and muscle were 0.65 (95% CI, 0.38-0.81), 0.47 (95% CI, 0.15-0.70), and 0.82 (95% CI, 0.65-0.91), respectively. The SUL coefficients of variation (CVs) were 9% for the ABP, 12% for the liver, and 10% for muscle. Similar results were obtained from the Bland-Altman plots. There was a positive correlation between the variations in the liver SUL and the BGL (b=0.60, P<0.01). A similar result was found between the variations in muscle SUL and the BGL (b=0.45, P<0.01). The variation in muscle SUL showed a positive correlation with the variation in the tracer uptake period (b=0.58, P<0.01).
CONCLUSIONS: The SUL of the liver is more sensitive to BGLs and, therefore, may not be suitable as a referential background. Activities within the ABP and muscle are more stable than those of the liver and should be used as the preferred background for sequential patient evaluation. 2021 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  18F-FDG PET/CT; Standardized uptake value normalized to lean body mass (SUL); background; intrapatient; repeatability

Year:  2021        PMID: 34476197      PMCID: PMC8339652          DOI: 10.21037/qims-20-769

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  34 in total

1.  Factors affecting intrapatient liver and mediastinal blood pool ¹⁸F-FDG standardized uptake value changes during ABVD chemotherapy in Hodgkin's lymphoma.

Authors:  Agostino Chiaravalloti; Roberta Danieli; Paolo Abbatiello; Barbara Di Pietro; Laura Travascio; Maria Cantonetti; Manlio Guazzaroni; Antonio Orlacchio; Giovanni Simonetti; Orazio Schillaci
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-22       Impact factor: 9.236

2.  Role of the liver in glucose homeostasis.

Authors:  R S Sherwin
Journal:  Diabetes Care       Date:  1980 Mar-Apr       Impact factor: 19.112

3.  Glucose uptake patterns in exercised skeletal muscles of elite male long-distance and short-distance runners.

Authors:  Suh-Jun Tai; Ren-Shyan Liu; Ya-Chen Kuo; Chi-Yang Hsu; Chi-Hsien Chen
Journal:  Chin J Physiol       Date:  2010-04-30       Impact factor: 1.764

4.  Insulin stimulates liver glucose uptake in humans: an 18F-FDG PET Study.

Authors:  Patricia Iozzo; Fabian Geisler; Vesa Oikonen; Maija Mäki; Teemu Takala; Olof Solin; Ele Ferrannini; Juhani Knuuti; Pirjo Nuutila
Journal:  J Nucl Med       Date:  2003-05       Impact factor: 10.057

Review 5.  From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.

Authors:  Richard L Wahl; Heather Jacene; Yvette Kasamon; Martin A Lodge
Journal:  J Nucl Med       Date:  2009-05       Impact factor: 10.057

6.  Ischemia induces translocation of the insulin-responsive glucose transporter GLUT4 to the plasma membrane of cardiac myocytes.

Authors:  D Sun; N Nguyen; T R DeGrado; M Schwaiger; F C Brosius
Journal:  Circulation       Date:  1994-02       Impact factor: 29.690

7.  Reference range for intrapatient variability in blood-pool and liver SUV for 18F-FDG PET.

Authors:  Raef R Boktor; Gregory Walker; Roderick Stacey; Samuel Gledhill; Alexander G Pitman
Journal:  J Nucl Med       Date:  2013-03-19       Impact factor: 10.057

8.  Variation of liver SUV on (18)FDG-PET/CT studies in women with breast cancer.

Authors:  David Groheux; Marc Delord; Domenico Rubello; Patrick M Colletti; Minh-Loan Nguyen; Elif Hindié
Journal:  Clin Nucl Med       Date:  2013-06       Impact factor: 7.794

9.  Influence of dietary state and insulin on myocardial, skeletal muscle and brain [F]-fluorodeoxyglucose kinetics in mice.

Authors:  Michael C Kreissl; David B Stout; Koon-Pong Wong; Hsiao-Ming Wu; Evren Caglayan; Waldemar Ladno; Xiaoli Zhang; John O Prior; Christoph Reiners; Sung-Cheng Huang; Heinrich R Schelbert
Journal:  EJNMMI Res       Date:  2011-07-06       Impact factor: 3.138

10.  Quantifying the contribution of the liver to glucose homeostasis: a detailed kinetic model of human hepatic glucose metabolism.

Authors:  Matthias König; Sascha Bulik; Hermann-Georg Holzhütter
Journal:  PLoS Comput Biol       Date:  2012-06-21       Impact factor: 4.475

View more
  1 in total

1.  Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor.

Authors:  Gerben J C Zwezerijnen; Jakoba J Eertink; Maria C Ferrández; Sanne E Wiegers; Coreline N Burggraaff; Pieternella J Lugtenburg; Martijn W Heymans; Henrica C W de Vet; Josée M Zijlstra; Ronald Boellaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-09-27       Impact factor: 10.057

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.